Seyyedi Seyed Reza, Tabarsi Payam, Sadr Makan, Aloosh Oldooz, Keshmiri Mohammad Sadegh, Abedini Atefeh, Marjani Majid, Moniri Afshin, Chitsazan Mandana, Azimi Mojdeh, Sharif-Kashani Babak
Lung Transplantation Research Center, Department of Cardiology, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical Tuberculosis and Epidemiology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2021 Feb;20(2):134-139.
The study aimed to evaluate the effectiveness and safety of BAE in TB patient with massive hemoptysis and evaluate the recurrence rate of hemoptysis after BAE.
In this prospective study, 68 patients with moderate and severe hemoptysis due to active or old tuberculosis who underwent bronchial arteriography were included. CXR and CT scan were performed in all patients. Selective and nonselective bronchial artery angiography was performed in all patient and 62 patients underwent embolization.
Thirty-two patients (47.1%) had active TB and 36 patients (52.9%) had inactive TB (post-tuberculosis sequelae). Abnormality was detected in a single vessel in 30 (44.1%) patients, in two vessels in 23 (33.8%) and in more than two vessels in 13 (19.1%) patients. Embolization was performed in 62 patients and overall 95 abnormal arteries were embolized. Hemoptysis control rate was 82.3% at one month, 73.5% at three months, 69.1 % at 6 months, 63.2% at one year and 60.3% after two years.
No major complication occurred as a result of BAE procedures. BAE is a safe and effective method for the management of hemoptysis in patient with tuberculosis. Only 20.6% of the patients need to repeat BAE during 2 years of follow up.
本研究旨在评估支气管动脉栓塞术（BAE）治疗大量咯血的肺结核患者的有效性和安全性，并评估BAE术后咯血的复发率。
在这项前瞻性研究中，纳入了68例因活动性或陈旧性肺结核导致中重度咯血并接受支气管动脉造影的患者。所有患者均进行了胸部X线（CXR）和CT扫描。所有患者均进行了选择性和非选择性支气管动脉造影，62例患者接受了栓塞治疗。
32例患者（47.1%）为活动性肺结核，36例患者（52.9%）为非活动性肺结核（肺结核后遗症）。30例（44.1%）患者的单个血管出现异常，23例（33.8%）患者的两个血管出现异常，13例（19.1%）患者的两个以上血管出现异常。62例患者接受了栓塞治疗，共栓塞了95条异常动脉。咯血控制率在1个月时为82.3%，在3个月时为73.5%，在6个月时为69.1%，在1年时为63.2%，在2年后为60.3%。
BAE手术未导致严重并发症。BAE是治疗肺结核患者咯血的一种安全有效的方法。在2年的随访中，只有20.6%的患者需要重复BAE。
